Across TCGA patient cohorts, RNY4P30 mutation is significantly associated with the total protein of many other genes, with 32 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible RNY4P30-associated genes across cancer lineages are ATM, 14-3-3_beta, and eIF4E. Each is linked with RNY4P30 in more than 1 cancer types. Because this analysis shows association rather than direction, both RNY4P30-to-partner and partner-to-RNY4P30 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (RNY4P30→partner) and Y-score (partner→RNY4P30) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	ATM →	-0.519	-2.087	.002	.005	3	2
UCEC	14-3-3_beta →	-0.082	-2.295	.033	.033	3	1
UCEC	eIF4E →	+0.177	+2.087	.028	.005	3	1
UCEC	A-Raf_pS299 →	-0.101	-3.169	.026	.018	3	1
UCEC	Fibronectin →	-0.332	-3.446	.008	.005	3	1
UCEC	JNK_pT183_Y185 →	-0.211	-3.700	.001	.001	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 32 associations by consensus.

Exploration

RNY4P30 survival (RNA) · tumor vs normal (RNA) · all RNY4P30 data types